Evidence map›Paper›PMID 35384344›Full record

ArticleClinical and translational medicine2022

Role of integrin expression in the prediction of response to vedolizumab: A prospective real-life multicentre cohort study.

Cara De Galan, Gerard Bryan Gonzales, Sophie Van Welden, Simon Jan Tavernier, Triana Lobaton, Wouter Van Moerkercke, Beatrijs Strubbe, Harald Peeters, Elisabeth Macken, Martine De Vos and 2 more

Abstract readLetterMulticenter Study
PubMed Full text at PMC Publisher
In one paragraph

Article in Clinical and translational medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Cara De GalanDepartment of Internal Medicine and Paediatrics, Ghent University, Ghent, Belgium.
Gerard Bryan GonzalesDepartment of Internal Medicine and Paediatrics, Ghent University, Ghent, Belgium.ORCID 0000-0001-6614-3520
Sophie Van WeldenDepartment of Internal Medicine and Paediatrics, Ghent University, Ghent, Belgium.
Simon Jan TavernierPrimary Immune Deficiency Research Lab, Centre for Primary Immunodeficiency Ghent, Jeffrey Model Diagnosis and Research Centre, Ghent University Hospital, Ghent, Belgium.
Triana LobatonDepartment of Internal Medicine and Paediatrics, Ghent University, Ghent, Belgium.
Wouter Van MoerkerckeDepartment of Gastroenterology, AZ Groeninge, Kortrijk, Belgium.
Beatrijs StrubbeDepartment of Gastroenterology, AZ Sint-Lucas Ghent, Ghent, Belgium.
Harald PeetersDepartment of Gastroenterology, AZ Sint-Lucas Ghent, Ghent, Belgium.
Elisabeth MackenDepartment of Gastroenterology, University Hospital Antwerp, Antwerp, Belgium.
Martine De VosDepartment of Internal Medicine and Paediatrics, Ghent University, Ghent, Belgium.
Debby LaukensDepartment of Internal Medicine and Paediatrics, Ghent University, Ghent, Belgium.ORCID 0000-0002-1984-5850
Pieter HindryckxDepartment of Internal Medicine and Paediatrics, Ghent University, Ghent, Belgium.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Antibodies, Monoclonal, HumanizedIntegrinsGastrointestinal AgentsHumansProspective StudiesAntibodies, Monoclonal, HumanizedGastrointestinal AgentsIntegrinsvedolizumab

Identifiers

PMID35384344
PMCPMC8982506

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.